Show simple item record

dc.contributor.authorNtalla, Ien_US
dc.contributor.authorKanoni, Sen_US
dc.contributor.authorZeng, Len_US
dc.contributor.authorGiannakopoulou, Oen_US
dc.contributor.authorDanesh, Jen_US
dc.contributor.authorWatkins, Hen_US
dc.contributor.authorSamani, NJen_US
dc.contributor.authorDeloukas, Pen_US
dc.contributor.authorSchunkert, Hen_US
dc.contributor.authorUK Biobank CardioMetabolic Consortium CHD Working Groupen_US
dc.date.accessioned2019-07-09T08:25:59Z
dc.date.available2019-03-19en_US
dc.date.issued2019-06-18en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/58416
dc.description.abstractBACKGROUND: The taxonomy of cardiovascular (CV) diseases is divided into a broad spectrum of clinical entities. Many such diseases coincide in specific patient groups and suggest shared predisposition. OBJECTIVES: This study focused on coronary artery disease (CAD) and investigated the genetic relationship to CV and non-CV diseases with reported CAD comorbidity. METHODS: This study examined 425,196 UK Biobank participants to determine a genetic risk score (GRS) based on 300 CAD associated variants (CAD-GRS). This score was associated with 22 traits, including risk factors, diseases secondary to CAD, as well as comorbid and non-CV conditions. Sensitivity analyses were performed in individuals free from CAD or stable angina diagnosis. RESULTS: Hypercholesterolemia (odds ratio [OR]: 1.27; 95% CI: 1.26 to 1.29) and hypertension (OR: 1.11; 95% CI: 1.10 to 1.12) were strongly associated with the CAD-GRS, which indicated that the score contained variants predisposing to these conditions. However, the CAD-GRS was also significant in patients with CAD who were free of CAD risk factors (OR: 1.37; 95% CI: 1.30 to 1.44). The study observed significant associations between the CAD-GRS and peripheral arterial disease (OR: 1.28; 95% CI: 1.23 to 1.32), abdominal aortic aneurysms (OR: 1.28; 95% CI: 1.20 to 1.37), and stroke (OR: 1.08; 95% CI: 1.05 to 1.10), which remained significant in sensitivity analyses that suggested shared genetic predisposition. The score was also associated with heart failure (OR: 1.25; 95% CI: 1.22 to 1.29), atrial fibrillation (OR: 1.08; 95% CI: 1.05 to 1.10), and premature death (OR: 1.04; 95% CI: 1.02 to 1.06). These associations were abolished in sensitivity analyses that indicated that they were secondary to prevalent CAD. Finally, an inverse association was observed between the score and migraine headaches (OR: 0.94; 95% CI: 0.93 to 0.96). CONCLUSIONS: A wide spectrum of CV conditions, including premature death, might develop consecutively or in parallel with CAD for the same genetic roots. In conditions like heart failure, the study found evidence that the CAD-GRS could be used to stratify patients with no or limited genetic overlap with CAD risk. Increased genetic predisposition to CAD was inversely associated with migraine headaches.en_US
dc.description.sponsorshipNational Institute of Health Research (NIHR) Barts Biomedical Research Centre - NIHR (IS-BRC-1215-20022)en_US
dc.description.sponsorshipFondation Leducq (CADgenomics, 12CVD02)en_US
dc.description.sponsorshipSonderforschungsbereich CRC 1123 (B2)en_US
dc.description.sponsorshipGerman Federal Ministry of Education and Research (BMBF) (ERA-CVD: grant JTC2017_21-040)en_US
dc.format.extent2932 - 2942en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofJ Am Coll Cardiolen_US
dc.rights© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectUK Biobanken_US
dc.subjectcardiovascular diseasesen_US
dc.subjectcoronary artery diseaseen_US
dc.subjectgenetic risk scoreen_US
dc.subjectheart failureen_US
dc.subjectmigraineen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectArthritis, Rheumatoiden_US
dc.subjectBiological Specimen Banksen_US
dc.subjectCohort Studiesen_US
dc.subjectCoronary Artery Diseaseen_US
dc.subjectFemaleen_US
dc.subjectGenetic Predisposition to Diseaseen_US
dc.subjectHumansen_US
dc.subjectHypercholesterolemiaen_US
dc.subjectHypertensionen_US
dc.subjectKidney Diseasesen_US
dc.subjectLongitudinal Studiesen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectProspective Studiesen_US
dc.subjectRisk Assessmenten_US
dc.subjectRisk Factorsen_US
dc.subjectUnited Kingdomen_US
dc.titleGenetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.en_US
dc.typeArticle
dc.identifier.doi10.1016/j.jacc.2019.03.512en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/31196449en_US
pubs.issue23en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume73en_US
dcterms.dateAccepted2019-03-19en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record